# The Role of a Novel Obesity-Risk Variant on Hypothalamic Regulation of Energy Homeostasis

> **NIH NIH R21** · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2021 · $195,625

## Abstract

The current obesity epidemic warrants improved strategies for preventing and treating this increasingly
devastating disease. Recently, our collaborative group examined the obesity-prone Samoan population and
identified a missense variant in a putative transcriptional regulator (CREBRFR457Q) that increases BMI and
adiposity. Little is understood about CREBRF and even less for the mechanisms by which its obesity-risk variant
influence these phenotypes in humans. Because food intake, energy expenditure, and fat storage are
orchestrated between the periphery and the brain, we examined in murine models that CREBRF was expressed
and enriched in the hypothalamus throughout embryonic development and in adulthood is regulated during
feeding state in a cell-specific manner. Therefore, the overall objective of this proposal is to understand how
CREBRF and its obesity-risk variant contribute to the central regulation of energy homeostasis and, more
specifically, to the development and function of POMC and AgRP neurons in the arcuate nucleus of the
hypothalamus during nutritional stress in a sex-specific manner. Our central hypothesis is that CREBRF and its
obesity-risk variant influence proliferation, differentiation, and subsequent activation/output of key hypothalamic
neurons that control food intake, energy expenditure, and body weight. This hypothesis is supported by the
following preliminary data: 1) humans expressing the CREBRFR457Q variant have increased BMI and adiposity,
2) mice lacking CREBRF have reduced body weight and food intake, 3) wild type CREBRF is reciprocally
regulated in POMC and AgRP neurons in response to fasting, and 4) CREBRF is expressed in the embryonic
hypothalamus and induced corresponding with neurogenesis. The central hypothesis will be tested using
available cell and mouse models to achieve the following two specific aims: 1) to determine the impact of
CREBRF and its obesity-risk variant on embryonic hypothalamic development, and 2) to determine the impact
of CREBRF and its obesity-risk variant on gene expression in key adult hypothalamic neurons that regulate
energy balance during various feeding states. This research is innovative because it uses a multidisciplinary
approach and state-of-the-art techniques to elucidate mechanisms by which a novel human obesity-risk variant
in a poorly understood gene influences the central regulation of energy homeostasis. This research is significant
because it is directly relevant to populations with a high prevalence of the risk allele and because it is likely to
reveal novel insights into the general regulation of energy homeostasis and pathogenesis of more common
obesity in humans. These findings are expected to have broad translational impact because they will provide
fundamental understanding for a relatively unknown gene and reveal novel mechanisms that can be targeted for
prevention and/or treatment of obesity in a sex-specific manner. Additionally, this NIDDK R21 will support the
g...

## Key facts

- **NIH application ID:** 10218152
- **Project number:** 5R21DK121266-03
- **Recipient organization:** UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- **Principal Investigator:** Krystle Anne Frahm
- **Activity code:** R21 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $195,625
- **Award type:** 5
- **Project period:** 2019-09-13 → 2023-04-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10218152

## Citation

> US National Institutes of Health, RePORTER application 10218152, The Role of a Novel Obesity-Risk Variant on Hypothalamic Regulation of Energy Homeostasis (5R21DK121266-03). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10218152. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*